Cargando…

Eighteen-Year Disease Progression and Survival in CADASIL

Detalles Bibliográficos
Autores principales:	Gravesteijn, Gido, Hack, Remco J., van Opstal, Anna M., van Eijsden, Bastian J., Middelkoop, Huub A.M., Rodriguez Girondo, Mar D.M., Aartsma-Rus, Annemieke, van de Grond, Jeroen, Rutten, Julie W., Oberstein, Saskia A.J. Lesnik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Stroke Society 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900403/ https://www.ncbi.nlm.nih.gov/pubmed/33600711 http://dx.doi.org/10.5853/jos.2020.04112

Ejemplares similares

Serum Neurofilament light correlates with CADASIL disease severity and survival
por: Gravesteijn, Gido, et al.
Publicado: (2018)

Effect of NOTCH3 EGFr Group, Sex, and Cardiovascular Risk Factors on CADASIL Clinical and Neuroimaging Outcomes
por: Hack, Remco J., et al.
Publicado: (2022)

NO TCH3 variant position is associated with NOTCH3 aggregation load in CADASIL vasculature
por: Gravesteijn, Gido, et al.
Publicado: (2021)

Archetypal NOTCH3 mutations frequent in public exome: implications for CADASIL
por: Rutten, Julie W., et al.
Publicado: (2016)

Broad phenotype of cysteine-altering NOTCH3 variants in UK Biobank: CADASIL to nonpenetrance
por: Rutten, Julie W., et al.
Publicado: (2020)

Naturally occurring NOTCH3 exon skipping attenuates NOTCH3 protein aggregation and disease severity in CADASIL patients
por: Gravesteijn, Gido, et al.
Publicado: (2020)

Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy Family Members With a Pathogenic NOTCH3 Variant Can Have a Normal Brain Magnetic Resonance Imaging and Skin Biopsy Beyond Age 50 Years
por: Hack, Remco J., et al.
Publicado: (2022)

Cognition, mood and behavior in CADASIL
por: Chabriat, Hugues, et al.
Publicado: (2022)

Three-tiered EGFr domain risk stratification for individualized NOTCH3-small vessel disease prediction
por: Hack, Remco J, et al.
Publicado: (2022)

The NOTCH3 score: a pre-clinical CADASIL biomarker in a novel human genomic NOTCH3 transgenic mouse model with early progressive vascular NOTCH3 accumulation
por: Rutten, Julie W., et al.
Publicado: (2015)

Commentary to: Masoli et al. Clinical Outcomes of CADASIL-Associated NOTCH3 mutations in 451,424 European Ancestry Community Volunteers. (Translational Stroke Research Oct 2018)
por: Rutten, J. W., et al.
Publicado: (2018)

In-Depth Characterization of Protein Disulfide Bonds by Online Liquid Chromatography-Electrochemistry-Mass Spectrometry
por: Switzar, Linda, et al.
Publicado: (2015)

Progression and Classification of Granular Osmiophilic Material (GOM) Deposits in Functionally Characterized Human NOTCH3 Transgenic Mice
por: Gravesteijn, Gido, et al.
Publicado: (2019)

The effect of NOTCH3 pathogenic variant position on CADASIL disease severity: NOTCH3 EGFr 1–6 pathogenic variant are associated with a more severe phenotype and lower survival compared with EGFr 7–34 pathogenic variant
por: Rutten, Julie W., et al.
Publicado: (2018)

Correction: The effect of NOTCH3 pathogenic variant position on CADASIL disease severity: NOTCH3 EGFr 1–6 pathogenic variant are associated with a more severe phenotype and lower survival compared with EGFr 7–34 pathogenic variant
por: Rutten, Julie W., et al.
Publicado: (2018)

Active immunotherapy reduces NOTCH3 deposition in brain capillaries in a CADASIL mouse model
por: Oliveira, Daniel V, et al.
Publicado: (2022)

Cysteine-Altering NOTCH3 Variants Are a Risk Factor for Stroke in the Elderly Population
por: Hack, Remco J., et al.
Publicado: (2020)

The use of genetically humanized animal models for personalized medicine approaches
por: Aartsma-Rus, Annemieke, et al.
Publicado: (2019)

Good news for the mdx mouse community: Improved dystrophin restoration after skipping mouse dystrophin exon 23
por: Aartsma-Rus, Annemieke
Publicado: (2022)

Moving neuromuscular disorders research forward: from novel models to clinical studies
por: van Putten, Maaike, et al.
Publicado: (2020)

Eighteen new species of Neotropical Costaceae (Zingiberales)
por: Maas, Paul J. M., et al.
Publicado: (2023)

FDA Approves Eteplirsen for Duchenne Muscular Dystrophy: The Next Chapter in the Eteplirsen Saga
por: Aartsma-Rus, Annemieke, et al.
Publicado: (2017)

Eighteen papers on algebra
por: Brudno, A L, et al.
Publicado: (1963)

Going on Eighteen
Publicado: (1902)

Circulating Biomarkers for Duchenne Muscular Dystrophy
por: Aartsma-Rus, Annemieke, et al.
Publicado: (2015)

CADASIL and CARASIL
por: Tikka, Saara, et al.
Publicado: (2014)

Eighteen Trios from the classic masters: For two flutes and clarinet or flute, oboe and clarinet
por: Leeuwen, Ary Van

The comparisons of phenotype and genotype between CADASIL and CADASIL-like patients and population-specific evaluation of CADASIL scale in China
por: He, Dan, et al.
Publicado: (2016)

Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) as a model of small vessel disease: update on clinical, diagnostic, and management aspects
por: Di Donato, Ilaria, et al.
Publicado: (2017)

Nonclinical Exon Skipping Studies with 2′-O-Methyl Phosphorothioate Antisense Oligonucleotides in mdx and mdx-utrn−/− Mice Inspired by Clinical Trial Results
por: van Putten, Maaike, et al.
Publicado: (2019)

Assessment of Behavioral Characteristics With Procedures of Minimal Human Interference in the mdx Mouse Model for Duchenne Muscular Dystrophy
por: Engelbeen, Sarah, et al.
Publicado: (2021)

Changes in brain activity after weight loss
por: van Opstal, A. M., et al.
Publicado: (2019)

The Effect of 6-Thioguanine on Alternative Splicing and Antisense-Mediated Exon Skipping Treatment for Duchenne Muscular Dystrophy
por: Verhaart, Ingrid E. C., et al.
Publicado: (2012)

Antisense-induced exon skipping for duplications in Duchenne muscular dystrophy
por: Aartsma-Rus, Annemieke, et al.
Publicado: (2007)

The potential danger of blocking CGRP for treating migraine in CADASIL patients
por: de Boer, Irene, et al.
Publicado: (2020)

The History of the College Library: The Eighteen-Seventies
por: Payne, L.M., et al.
Publicado: (1984)

The Dilemma of Choice for Duchenne Patients Eligible for Exon 51 Skipping The European Experience
por: Aartsma-Rus, Annemieke, et al.
Publicado: (2023)

Neuropsychiatric manifestations in CADASIL
por: Chabriat, Hugues, et al.
Publicado: (2007)

CADASIL: case report
por: da Silva, Julio Cesar Vasconcelos, et al.
Publicado: (2012)

Clinical patterns in CADASIL
por: Gailani, G., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3ecjcdd3m0hq1bcev55b7opt9k